2019
DOI: 10.1021/jacs.9b06229
|View full text |Cite
|
Sign up to set email alerts
|

A Nucleic Acid Nanostructure Built through On-Electrode Ligation for Electrochemical Detection of a Broad Range of Analytes

Abstract: For an assay to be most effective in point-of-care clinical analysis, it needs to be economical, simple, generalizable, and free from tedious workflows. While electrochemistry-based DNA sensors reduce instrumental costs and eliminate complicated procedures, there remains a need to address probe costs and generalizability, as numerous probes with multiple conjugations are needed to quantify a wide range of biomarkers. In this work, we have opened a route to circumvent complicated multi-conjugation schemes using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
54
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(56 citation statements)
references
References 34 publications
2
54
0
Order By: Relevance
“…[ 5 , 6 , 7 , 8 , 9 , 10 , 11 ] Sensitivity is a key consideration for many biomedical applications, because many clinical biomarkers are present at nanomolar to picomolar concentrations, and the biosensor must achieve sufficient sensitivity in a complex background of interferent molecules. [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ] Unfortunately, due to noise limitations in existing electronic measurement systems, the signal‐to‐noise ratio of conventional electrochemical biosensors degrades precipitously when they are miniaturized to the micron scale, [ 21 ] reducing their sensitivity and making meaningful measurements of analyte concentrations challenging or even impossible in many cases. [ 22 , 23 ]…”
Section: Introductionmentioning
confidence: 99%
“…[ 5 , 6 , 7 , 8 , 9 , 10 , 11 ] Sensitivity is a key consideration for many biomedical applications, because many clinical biomarkers are present at nanomolar to picomolar concentrations, and the biosensor must achieve sufficient sensitivity in a complex background of interferent molecules. [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ] Unfortunately, due to noise limitations in existing electronic measurement systems, the signal‐to‐noise ratio of conventional electrochemical biosensors degrades precipitously when they are miniaturized to the micron scale, [ 21 ] reducing their sensitivity and making meaningful measurements of analyte concentrations challenging or even impossible in many cases. [ 22 , 23 ]…”
Section: Introductionmentioning
confidence: 99%
“…This approach has been used to realize electrochemical detection of a broad range of analytes by employing the concept of on-electrode ligation. 163 The molecular sensor consisted of three DNA modules. The first was an anchor module that was immobilized on a gold electrode by a thiol group.…”
Section: Modularizationmentioning
confidence: 99%
“…Indeed, electrochemical sensors for glucose and lactate are the dominant sensors used for the development of dynamic detection systems for monitoring in physiological systems because redox-active enzymes can be used to report on the presence of the target analytes in the absence of added reporters. Reagentless electrochemical sensors that are instead affinitybased and compatible with in vivo monitoring applications have been generated based on DNA aptamers that serve as recognition elements [13][14][15][16][17][18] . While powerful for the collection of pharmacokinetic data in living systems where analyte concentrations are high, aptamer-based sensors typically have low binding affinities that render them incompatible with many sensing applications.…”
Section: Introductionmentioning
confidence: 99%